259 related articles for article (PubMed ID: 33939332)
21. Severe interstitial lung disease associated with amrubicin treatment.
Yoh K; Kenmotsu H; Yamaguchi Y; Kubota K; Ohmatsu H; Goto K; Niho S; Ohe Y; Saijo N; Nishiwaki Y
J Thorac Oncol; 2010 Sep; 5(9):1435-8. PubMed ID: 20683210
[TBL] [Abstract][Full Text] [Related]
22. Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.
Akaike K; Saruwatari K; Okabayashi H; Hamada S; Jodai Y; Jodai T; Sakata S; Iyama S; Sato R; Iriki T; Tomita Y; Saeki S; Ichiyasu H; Fujii K
Anticancer Res; 2018 Nov; 38(11):6543-6550. PubMed ID: 30396984
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.
Okuda K; Hirose T; Oki Y; Murata Y; Kusumoto S; Sugiyama T; Ishida H; Shirai T; Nakashima M; Yamaoka T; Ohnishi T; Ohmori T
Anticancer Res; 2012 Dec; 32(12):5475-80. PubMed ID: 23225454
[TBL] [Abstract][Full Text] [Related]
24. Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease.
Fujimoto D; Shimizu R; Kato R; Sato Y; Kogo M; Ito J; Teraoka S; Otoshi T; Nagata K; Nakagawa A; Otsuka K; Katakami N; Tomii K
Anticancer Res; 2015 Nov; 35(11):6261-6. PubMed ID: 26504060
[TBL] [Abstract][Full Text] [Related]
25. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease.
Otsuka K; Nokihara H; Mitsuhashi A; Ozaki R; Yabuki Y; Yoneda H; Ogino H; Nishioka Y
Thorac Cancer; 2022 Nov; 13(21):2978-2984. PubMed ID: 36106507
[TBL] [Abstract][Full Text] [Related]
27. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
[TBL] [Abstract][Full Text] [Related]
28. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis.
Izuka S; Yamashita H; Iba A; Takahashi Y; Kaneko H
Rheumatology (Oxford); 2021 May; 60(5):2348-2354. PubMed ID: 33241299
[TBL] [Abstract][Full Text] [Related]
29. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
30. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
Kobayashi H; Wakuda K; Naito T; Mamesaya N; Omori S; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Gon Y; Takahashi T
Radiat Oncol; 2021 Mar; 16(1):52. PubMed ID: 33731123
[TBL] [Abstract][Full Text] [Related]
32. Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy.
Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Takahashi T
J Cancer; 2018; 9(11):2054-2060. PubMed ID: 29896291
[No Abstract] [Full Text] [Related]
33. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
34. Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer.
Saito Y; Sasaki S; Oikado K; Tominaga J; Sata M; Sakai F; Kato T; Iwasawa T; Kenmotsu H; Kusumoto M; Baba T; Endo M; Fujiwara Y; Sugiura H; Yanagawa N; Ito Y; Sakamoto T; Ohe Y; Kuwano K
Cancer Sci; 2021 Apr; 112(4):1495-1505. PubMed ID: 33098725
[TBL] [Abstract][Full Text] [Related]
35. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
[TBL] [Abstract][Full Text] [Related]
36. Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease.
Enomoto Y; Inui N; Imokawa S; Karayama M; Hasegawa H; Ozawa Y; Matsui T; Yokomura K; Suda T
Cancer Chemother Pharmacol; 2015 Sep; 76(3):499-505. PubMed ID: 26134440
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease.
Yoshida T; Yoh K; Goto K; Niho S; Umemura S; Ohmatsu H; Ohe Y
Anticancer Res; 2013 Mar; 33(3):1175-9. PubMed ID: 23482799
[TBL] [Abstract][Full Text] [Related]
38. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
[TBL] [Abstract][Full Text] [Related]
39. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
40. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
